ProShare Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179M | Buy |
|
|||||
|
2025
Q1 | $186M | Buy |
|
|||||
|
2024
Q4 | $139M | Buy |
|
|||||
|
2024
Q3 | $136M | Buy |
|
|||||
|
2024
Q2 | $126M | Sell |
|
|||||
|
2024
Q1 | $126M | Buy |
|
|||||
|
2023
Q4 | $102M | Sell |
|
|||||
|
2023
Q3 | $103M | Buy |
|
|||||
|
2023
Q2 | $92.1M | Sell |
|
|||||
|
2023
Q1 | $88.2M | Buy |
|
|||||
|
2022
Q4 | $73.7M | Sell |
|
|||||
|
2022
Q3 | $81.6M | Sell |
|
|||||
|
2022
Q2 | $93.1M | Sell |
|
|||||
|
2022
Q1 | $128M | Sell |
|
|||||
|
2021
Q4 | $114M | Buy |
|
|||||
|
2021
Q3 | $67.7M | Buy |
|
|||||
|
2021
Q2 | $68.5M | Sell |
|
|||||
|
2021
Q1 | $74.1M | Buy |
|
|||||
|
2020
Q4 | $70.8M | Buy |
|
|||||
|
2020
Q3 | $71.5M | Buy |
|
|||||
|
2020
Q2 | $66.1M | Buy |
|
|||||
|
2020
Q1 | $47.7M | Sell |
|
|||||
|
2019
Q4 | $62.7M | Buy |
|
|||||
|
2019
Q3 | $46.2M | Buy |
|
|||||
|
2019
Q2 | $49.1M | Sell |
|
|||||
|
2019
Q1 | $54.6M | Buy |
|
|||||
|
2018
Q4 | $44.6M | Buy |
|
|||||
|
2018
Q3 | $46.8M | Sell |
|
|||||
|
2018
Q2 | $45.6M | Sell |
|
|||||
|
2018
Q1 | $51.4M | Buy |
|
|||||
|
2017
Q4 | $41.6M | Buy |
|
|||||
|
2017
Q3 | $33M | Buy |
|
|||||
|
2017
Q2 | $26M | Sell |
|
|||||
|
2017
Q1 | $24.1M | Sell |
|
|||||
|
2016
Q4 | $20.1M | Buy |
|
|||||
|
2016
Q3 | $20.2M | Sell |
|
|||||
|
2016
Q2 | $25M | Buy |
|
|||||
|
2016
Q1 | $22.7M | Sell |
|
|||||
|
2015
Q4 | $38.3M | Buy |
|
|||||
|
2015
Q3 | $28.8M | Sell |
|
|||||
|
2015
Q2 | $34.3M | Sell |
|
|||||
|
2015
Q1 | $36.5M | Buy |
|
|||||
|
2014
Q4 | $31.5M | Buy |
|
|||||
|
2014
Q3 | $23M | Sell |
|
|||||
|
2014
Q2 | $22.3M | Sell |
|
|||||
|
2014
Q1 | $20.2M | Buy |
|
|||||
|
2013
Q4 | $14M | Buy |
|
|||||
|
2013
Q3 | $8.56M | Buy |
|
|||||
|
2013
Q2 | $6.63M | Buy |
|